Projected Income Statement: Icade

Forecast Balance Sheet: Icade

Forecast Balance Sheet - Icade
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 6,933 6,876 3,448 3,454 3,446 3,053 2,732 2,551
Change - -0.82% -49.85% 0.17% -0.23% -11.41% -10.51% -6.63%
Announcement Date 2/21/22 2/20/23 2/19/24 2/18/25 2/17/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Icade

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,027 547.1 304.6 200.2 305.5 233 308.5 102
Change - -46.71% -44.32% -34.27% 52.6% -23.73% 32.4% -66.94%
Free Cash Flow (FCF) 1 -497.6 -234.2 1,318 166.2 236.8 667 499 572
Change - 52.93% 662.77% -87.39% 42.48% 181.67% -25.19% 14.63%
Announcement Date 2/21/22 2/20/23 2/19/24 2/18/25 2/17/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Icade

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 37.66% 35.82% 18.53% 15.2% 20.18% 20.83% 18.9% 18.6%
EBIT Margin (%) 48.2% 21.07% 17.68% 17.65% 20.32% 23.17% 21.79% 20.43%
EBT Margin (%) 38.82% 13.68% -87.6% -21.85% -7.48% - 12.95% 16.51%
Net margin (%) 24.09% 2.98% -81.85% -17.55% -8.49% -5.96% 13.3% 16.07%
FCF margin (%) -29.96% -12.9% 86.28% 10.57% 16.34% 52.02% 36.3% 39.88%
FCF / Net Income (%) -124.37% -432.9% -105.41% -60.24% -192.52% -873.42% 272.94% 248.15%

Profitability

        
ROA 2.3% 2.33% -8.39% -2.49% 2.7% 2.5% 2.56% 2.77%
ROE 6.07% 6.26% 6.06% 6.48% 6.62% 6% 6.02% 5.96%

Financial Health

        
Leverage (Debt/EBITDA) 11.08x 10.57x 12.19x 14.45x 11.78x 11.43x 10.52x 9.56x
Debt / Free cash flow -13.93x -29.36x 2.62x 20.78x 14.55x 4.58x 5.48x 4.46x

Capital Intensity

        
CAPEX / Current Assets (%) 61.82% 30.13% 19.94% 12.74% 21.07% 18.17% 22.44% 7.11%
CAPEX / EBITDA (%) 164.14% 84.13% 107.63% 83.77% 104.44% 87.23% 118.76% 38.22%
CAPEX / FCF (%) -206.33% -233.6% 23.11% 120.46% 129.01% 34.93% 61.82% 17.83%

Items per share

        
Cash flow per share 1 7.046 4.134 4.063 4.831 3.955 2.981 2.9 2.902
Change - -41.32% -1.72% 18.9% -18.13% -24.63% -2.73% 0.09%
Dividend per Share 1 4.2 4.33 4.84 4.31 1.92 1.76 1.826 1.929
Change - 3.1% 11.78% -10.95% -55.45% -8.35% 3.76% 5.64%
Book Value Per Share 1 88.8 86.94 65.8 57 50.86 48.42 49.18 49.97
Change - -2.1% -24.32% -13.36% -10.78% -4.8% 1.57% 1.61%
EPS 1 5.328 0.7136 -16.5 -3.64 -1.62 -1.177 2.045 2.876
Change - -86.61% -2,412.22% 77.94% 55.49% 27.35% 273.77% 40.63%
Nbr of stocks (in thousands) 75,691 75,652 75,770 75,778 75,825 75,797 75,797 75,797
Announcement Date 2/21/22 2/20/23 2/19/24 2/18/25 2/17/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -12.6x 7.23x
PBR 0.31x 0.3x
EV / Sales 3.25x 2.8x
Yield 11.9% 12.4%

EPS & Dividend

EPS & Dividend - Icade


Y-o-Y evolution of P/E

Valuation ratios - P/E - Icade
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Icade
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Icade
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
11
Last Close Price
14.78EUR
Average target price
19.35EUR
Spread / Average Target
+30.95%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Icade